Your Recent Quotes: 0 | 0

Martek Biosciences Corporation

Related Information and Financials
Price Glossary Definition
36.77
1.04%
7/23/08 4:00
Open
36.41
Prev Close
36.39
Volume
564,809
52 Wk. Range
24-38
Year-to-Date Performance Glossary Definition
Latest Dividend
Dividend
N/A
Yield
N/A
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
27.09
 
27.10
 
17.50
MATK
Sect. Av.
S&P 500
Market Cap
1,153,350,000
Outstanding Shares
32,863,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy MATK Rating Report
Target Price (1Yr)
High
37.00
Revenue
351,370,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
13.40
0.66
0.18
Net Income
79.70
-0.32
-0.12
EPS
78.20
-0.39
-0.15

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
0.17
31.70
-22.11
Earnings Per Share($)

10/2005
 
 
 
0.49
10/2006
 
 
 
0.55
10/2007
 
 
 
0.99

Earnings
EBITDA
62,080,000
Revenue
306,813,000
Outside Analyst Rating History

7/24/08
1
Buy
7/24/08
1
Hold
7/24/08
2
Sell

Jim Cramer Portfolio
Find out now if MATK is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
  • S&P 500 (SPX.X)
  • Dow Jones (INDU)
  • Nasdaq (COMPX)
    Latest Headlines
    Brady Corp., Martek Biosciences, Rent-A-Center, D.R. Horton and Evergreen Solar all upgraded.

    7:01AM 05/01/08

    John Deere's impressive growth has been fueled by the growing global demand for food.

    7:38PM 02/28/08

    Biogen slumped in after-hours trading Wednesday.

    6:45PM 12/12/07

    China has big plans, Cramer is BMOC and kids' music rocks.

    12:10AM 06/20/07

    ADC Telecommunications climbs on an earnings beat.

    6:02PM 06/06/07

    Cooper Cos. slumps on lowered guidance.

    7:52PM 12/12/06

    He's co-founder and partner at Valhalla Partners.

    2:05PM 11/20/06

    Elan is higher.

    4:04PM 10/24/06

    The patents covered nutritional products.

    1:34PM 10/24/06

    The company says its products are derived from vegetables.

    3:28PM 10/11/06

    Understanding the Market

    Our Experts' Take at RealMoney
    Today's strong action should lead to more upside in this leading biotech stock.

    3:48PM 07/23/08

    The very stocks that had been most heavily shorted are rallying the hardest.

    11:47AM 07/23/08

    More Experts' Takes


    Premium Stock Ideas
    Is Cramer trading MATK in his Action Alerts Plus Portfolio?